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Abstract
Background: The development of Electronic Health Records (EHRs) in hospitals offers the ability to reuse data from
patient care activities for clinical research. EHR4CR is a European public-private partnership aiming to develop a
computerized platform that enables the re-use of data collected from EHRs over its network. However, the
reproducibility of queries may depend on attributes of the local data. Our objective was 1/ to describe the different
steps that were achieved in order to use the EHR4CR platform and 2/ to identify the specific issues that could
impact the final performance of the platform.
Methods: We selected three institutional studies covering various medical domains. The studies included a total of
67 inclusion and exclusion criteria and ran in two University Hospitals. We described the steps required to use the
EHR4CR platform for a feasibility study. We also defined metrics to assess each of the steps (including criteria
complexity, normalization quality, and data completeness of EHRs).
Results: We identified 114 distinct medical concepts from a total of 67 eligibility criteria Among the 114 concepts:
23 (20.2%) corresponded to non-structured data (i.e. for which transformation is needed before analysis), 92 (81%)
could be mapped to terminologies used in EHR4CR, and 86 (75%) could be mapped to local terminologies. We
identified 51 computable criteria following the normalization process. The normalization was considered by experts
to be satisfactory or higher for 64.2% (43/67) of the computable criteria. All of the computable criteria could be
expressed using the EHR4CR platform.
Conclusions: We identified a set of issues that could affect the future results of the platform: (a) the normalization
of free-text criteria, (b) the translation into computer-friendly criteria and (c) issues related to the execution of the
query to clinical data warehouses. We developed and evaluated metrics to better describe the platforms and their
result. These metrics could be used for future reports of Clinical Trial Recruitment Support Systems assessment
studies, and provide experts and readers with tools to insure the quality of constructed dataset.
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Background
The research and development of new drugs requires the
implementation of long, complex and costly processes [1].
Only clinical trials can provide the evidence of effective-
ness and prove the safety of a new drug before
commercialization. The design, deployment, and manage-
ment of large scale trials come at a high cost. In 2010, the
cost for the development of a new drug from early re-
search to regulatory approval was estimated to be from
$161 million to $1.8 billion. Approximately half of this
amount was attributable to the clinical phase [1]. In this
context, new approaches have been developed to reduce
the cost of drug research and development studies [2].
The growing development and use of Electronic
Health Records (EHRs) in hospitals offers the ability to
reuse data from patient care activities for clinical
research [3–5]. EHRs may include many types of data,
including demographics data, medical history, medica-
tions, laboratory test results, radiology images, vital
signs, and billing information. These data can be used to
aid the three steps of a clinical trial: to identify eligible
patients, to feed case report forms for ongoing studies,
and to more effectively identify and notify adverse drug
reactions [6]. However, EHR software and structure are
neither dedicated nor adapted for clinical research.
Clinical Trial Recruitment Support Systems (CTRSS)s
have been developed over the past decade to reuse data
from EHRs for clinical research purpose [7]. CTRSSs
can translate a set of eligibility criteria into a set of com-
putable queries that can be run against an EHR to iden-
tify suitable patients for recruitment [8–11]. CTRSSs
can be used to evaluate protocol feasibility (i.e. to
identify and track patients with respect to inclusion cri-
teria for future studies) and help conduct studies.
CTRSSs provide access to patient data throughout the
hospital (they are not limited to one service or one
department) and may identify more eligible patients than
traditional methods and increase the accrual rate of
studies. Beauharnais has suggested that CTRSSs could
decrease the cost of drug development by decreasing the
time spent to deploy a study and improving clinical
recruitment [12].
There are many CTRSSs with various levels of cover-
age [13]: locally for one research center, regionally (for a
group of clinics), or internationally. The implementation
of a given CTRSS at a specific site depends on many fac-
tors (for example the domain covered, or the standard
terminology used). Comparing the usability of platforms
can be difficult. Indeed, the deployment of such plat-
forms raises new and complex issues. For example, how
to translate eligibility criteria, usually expressed as free
text, into computable formal queries that can be run
against EHRs, or whether primary care data can be used
to support research, and to what extent.
EHR4CR (Electronic Health Records for Clinical Re-
search) is one of the largest public-private partnerships
aiming to develop a computer platform to enable the re-
use of data collected from EHRs located in university
hospitals across Europe to support clinical research at all
steps of the process. The objective of this project is to
develop, deploy, and assess an innovative computer plat-
form capable of simplifying all the tasks of CTRSSs.
The EHR4CR model has been developed and assessed
on studies from industrial EFPIA (European Federation
of Pharmaceutical Industries and Associations) partners
[14]. While industry-sponsored studies mainly aim to as-
sess the efficacy of new drugs, academic studies often
cover a broader range of medical fields (e.g. non-
interventional studies for routine care, new surgical pro-
cedures, or the assessment of new diagnostic tools).
Such differences could affect the platform’s deployment
and its final performance. Consequently, it was crucial
to assess whether the EHR4CR platform could also be
used in the specific context of institutional clinical
studies.
Köpcke et al. performed a systematic literature review
of CTRSS research published up to the end of 2013 [13].
They analyzed 101 papers on 79 different systems and
concluded that “the success of a CTRSS depends more
on its successful workflow integration than on sophisti-
cated reasoning and data processing algorithms”. They
highlighted the fact that most of the CTRSS reports suf-
fered from the lack of a description of meaningful out-
comes such as intermediary criteria representation,
terminologies used, and the availability of patient data.
They proposed a list of 15 items to ensure that future
CTRSS design, implementation, and evaluation studies
are “sufficiently described to allow researchers to better
learn from other’s experience”.
Our objective was 1/ to describe and to provide out-
comes on the different steps that were achieved using
the EHR4CR platform for the support of our institu-
tional studies, 2/ to identify the specific issues that could
affect the final results of the platform.
Methods
HEGP and UKM clinical data warehouses
HEGP (Georges Pompidou European Hospital) is a 700
bed teaching hospital in Paris, France. HEGP deployed a
clinical data warehouse (CDW) based on the i2b2 frame-
work in 2008. The CDW collects from the hospital
information system structured data (data directly re-
usable for further analysis, e.g. demographics, diagnosis
codes, procedures, drug prescriptions, laboratory test re-
sults…) and unstructured data (i.e. data that need to be
transformed before secondary use, including, but not
limited to data stored in free-text format such as radi-
ology reports or discharge summaries) [15, 16]. The
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CDW has been a support for the deployment of the
EHR4CR platform at HEGP.
UKM (Munster University Hospital) is a 1400 bed
teaching hospital in Münster, Germany. The Westfälische
Wilhelms-Universität Münster (WWU) set up a CDW for
the EHR4CR project with the project’s “native DB
schema”. Because the CDW is not productively used, vari-
ous tools have been developed to evaluate various tasks
and scenarios of the project. There are currently “extract
transform load” (ETL) scripts for subjects, diagnoses, pro-
cedures, tumor node metastasis classification, clinical pa-
rameters, and medications.
Local terminologies (Table 1)
Local terminologies used at HEGP and UKM for the
project are described in Table 1.
EHR4CR architecture
The EHR4CR platform is based on a distributed service-
oriented architecture on which several components are
connected to provide a collection of services for faster
clinical studies management. The EHR4CR platform in-
cludes a central workbench where the final user can (i)
write eligibility criteria by selecting standardized codes
[17] (SNOMED-CT, ICD-10, ATC, LOINC, etc.), (ii)
combine them with Boolean logic (AND, OR, NOT) and
temporal (AFTER, BEFORE) operators, and (iii) store
the script in a dedicated formal representation: the
ECLECTIC (Eligibility Criteria Language for Clinical
Trial Investigation and Construction) language [18]. For
feasibility studies, the constructed query is submitted to
a set of selected hospitals by the EHR4CR Orchestrator
component. The query is received at the hospital by the
EHR4CR endpoint. This component transforms the ini-
tial ECLECTIC query into a collection of SQL (Struc-
tured Query Language) queries run onto the hospital
local CDW. Before the SQL queries are processed, the
standardized codes may be converted into specific local
codes by using the EHR4CR local mapping server. The
patient numbers are sent back to the EHR4CR Central
Workbench by the EHR4CR Orchestrator which aggre-
gates the results to provide the number of patients
matching each eligibility criterion in the different sites.
Selected studies
We selected three institutional studies: two conducted at
HEGP (aXa, DERENEDIAB) and one at UKM (EWING
2008):
– The aXa study [clinicaltrial.gov id: NCT02898051] is
a prospective case–control study with a high
enrollment rate. The goal of the aXa study is to
determine whether the pharmacokinetics of low
molecular weight heparin is predictive of recurrent
thromboembolism in cancer subjects.
– The DERENEDIAB study [clinicaltrial.gov id:
NCT01588795] is a multi-center, prospective, open,
randomized, controlled study, with a low enrollment
rate, to assess the effectiveness of renal denervation
in addition to standardized medical treatment in dia-
betic subjects with severe diabetic nephropathy.
– The EWING 2008 study [clinicaltrial.gov id:
NCT00987636] is an interventional, phase 3, multi-
center, randomized, controlled, international study
on Ewing Sarcoma.
Number of criteria are described in Table 2 for each
study.
The selected studies covered different medical do-
mains described by a variety of terminologies, and in-
cluded a large range of complex criteria. We chose
ongoing studies to be as close as possible of the real life
setting of the deployment of a clinical trial.




Biological results Local (partially mapped to LOINC) Local
Clinical parameters (pulse, temperature, …) Local Local
Diagnosis (final discharge) ICD-10 ICD10-GM
Medical Procedures CCAM (French medical procedure coding system) OPS (German procedure coding system)
Drug Prescriptions ATC Local
Clinical Reports None (free-text) None (free-text)
Demographic data Local Local
Complementary test reports None (free-text) None (free-text)
Pathological diagnosis ADICAP (French terminology for pathology) TNM
Chemotherapy Prescriptions Local ATC
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We extracted the inclusion/exclusion criteria from the
local Case Report Form. These three studies include a
total of 67 eligibility criteria which are listed in
Additional file 1.
Workflow
A/ Normalizing eligibility criteria
After collecting the eligibility criteria from the studies of
interest, we divided the normalization process of free-
text eligibility criteria to computable criteria into six
successive steps performed by a physician expert in
medical informatics (YG) (Table 3):
1- Remove redundancy among inclusion and exclusion
criteria: some exclusion criteria were only
complements of existing inclusion criteria.
2- Identify individual criteria, i.e. split a single complex
criterion into multiple simple criteria.
3- Reformulate criteria, e.g. negate and switch from
inclusion to exclusion: we transformed inclusion
criteria with a negative formulation into exclusion
criteria and conversely. This formulation was
imposed by the use of the ECLECTIC syntax.
4- Recognition of individual medical concepts: the
EHR4CR platform uses a set of international
terminologies to express eligibility criteria. We
manually identified all medical concepts present in
the free-text eligibility criteria that could be mapped
to any of the EHR4CR terminologies.
5- Remove semantic ambiguity (based on knowledge
sources or human expertise): some medical concepts
were too coarse-grained or too vague to allow useful
mapping to our local terminologies. We extended
concepts using the UMLS® or human expertise.
During this process, some criteria were removed as
they were too vague (i.e. no consensual definition)
or not computable and, therefore, not possible to
extend.
6- Translating medical concepts from local languages to
English: French and German versions of legacy
terminologies were used when available. They were
translated to English by a trained physician, when
necessary, and validated by a fluent English speaker.
B/ Expressing eligibility criteria with the EHR4CR platform
1/. Identify medical concepts using the platform
terminologies (ICD-10, SNOMED-CT, PathLex,
LOINC, ATC): semi-automatic concept recognition
We mapped individualized English-translated med-
ical concepts from eligibility criteria to medical
Table 2 Number of Inclusion and Exclusion Criteria for the





Inclusion criteria 9 7 10 10 36
Exclusion Criteria 11 5 10 5 31
Total 20 12 20 15 67
Table 3 Description and Examples of the Normalization Process of the Free-text Eligibility Criteria
Normalizing eligibility criteria in 6
steps
Before normalization process After normalization process
1- Remove redundancy among inclusion
and exclusion criteria
IC: no contraindication to low weight molecular
heparin
EC: any contraindication to low weight
molecular heparin
EC: any contraindication to low weight
molecular heparin
2- Identify individual criteria (e.g. split a
single complex criterion into multiple simple criteria)
IC: renal artery imaging dated less than 1 year
confirming the existence of two normal-sized
kidneys > 90 mm and showing no renal artery
stenosis
IC: renal artery imaging dated less than
1 year;
IC: kidney size > 90 mm;
IC: no renal artery stenosis
3- Reformulate criteria (e.g. negate and switch from
inclusion to exclusion)
IC: no renal artery stenosis EC: renal artery stenosis
(Negation removed)
4- Recognition of individual medical concepts: EC: known pregnancy or no effective contraception





5- Remove semantic ambiguity (based on
knowledge sources or human expertise)




- Impossible follow-up - No translation
6- Translating medical concepts from local
languages to English
EC: Grossesse connue ou absence de contraception
efficace pour les femmes en âge de procréer ou
allaitement.
EC: Known pregnancy or no effective
contraception for women of childbearing
age or breastfeeding
IC inclusion criterion, EC exclusion criterion
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concepts from the EHR4CR terminologies using the
UMLS Metathesaurus Browser [https://uts.nlm.nih.-
gov/]. We did not map medical concepts that corre-
sponded to unstructured data in the local EHRs
because the EHR4CR platform works only with
structured data.
2/.Translate the query into the ECLECTIC model [19])
We used the EHR4CR query platform to express the
normalized criteria into the ad-hoc ECLECTIC
syntax. ECLECTIC syntax allows the combination of
standardized concepts and Boolean or temporal
operators. For instance, we expressed the following
exclusion criterion “Known pregnancy or no
effective contraception for women of childbearing
age or breastfeeding” as follows:
“1. born() at most 18 year before now or
2. last diagnosis([SNOMED Clinical Terms:5935008,
“Oral contraception”])
3. and not last diagnosis([ICD-10:Z32.1, “Pregnancy
confirmed”])
4. and not last diagnosis([SNOMED Clinical
Terms:169750002, “Mother currently breast-
feeding”])”
C/ Executing the query on the local clinical data warehouse
We mapped medical concepts from the EHR4CR ter-
minologies to local CDW concepts. We performed auto-
matic mapping when the terminologies used in the
CDW were the same as those used in the EHR4CR plat-
form (e.g. ICD-10 and ATC terminologies are used by
both the HEGP-CDW and the EHR4CR platform). A
physician expert in medical informatics (YG) performed
other mappings using the browser of i2b2 Query and
Analysis tool.
Outcomes
We defined metrics in order to assess all the compo-
nents of the workflow described above:
A/ Normalization of free-text eligibility criteria
Each eligibility criterion was categorized according to
the proposition of Ross et al. as either “simple” or “com-
plex” [20]. A criterion was considered to be simple if it
could be expressed as a single concept (or the negation
of a single concept) or by a simple quantitative compari-
son. For example, criterion 1 from the aXa study “Age
>18”, can be expressed using concept C0001779 from
the UMLS associated with a quantitative comparison.
The other criteria were considered to be complex.
We calculated the number of criteria per study before
and after the 6-step normalization process, the number
of unchanged criteria after the normalization process,
and the number of final computable criteria i.e.
normalized criteria for which at least one medical con-
cept had been mapped to the local terminologies.
B/ Expressing eligibility criteria with the EHR4CR platform
We calculated the mapping rate between free-text
individualized concepts to EHR4CR terminologies as the
number of concepts that could be mapped to one or
more concepts of the terminologies used by the
EHR4CR platform divided by the total number of
concepts individualized in free text criteria.
We asked a PI to assess the agreement between free-
text eligibility criteria and computable criteria expressed
by ECLECTIC using a five-point Likert scale (5: perfect
without any information loss, 4: satisfactory, 3:
undecided, 2: not satisfactory, 1: not done).
C/ Executing the query on the local clinical data warehouse
We calculated the mapping rate from the medical con-
cepts of EHR4CR terminologies to the locally used
terminologies as the number of concepts that could be
mapped to one or more concepts of the EHR4CR
terminologies divided by the total number of concepts
expressed with the EHR4CR terminologies.
Coverage Information in the EHRs could be stored in
two different formats: structured and non-structured.
Examples of structured data are demographics, diagnosis
codes, laboratory test results, and so forth. An example
of non-structured data is free-text. The EHR4CR plat-
form dealt only with structured data. We labeled each
free-text individualized medical concept as “present and
structured” if it corresponded to structured data present
in the CDW/EHR; “present and unstructured” if it
corresponded to unstructured data, and “missing” if it
corresponded to data unavailable in the CDW/EHR.
We assessed completeness of the HEGP-CDW for each
medical concept individualized in eligibility criteria, i.e.
the number of distinct patients for which the informa-
tion was present in the CDW in 2013 divided by the
total number of distinct patients hospitalized at HEGP
during the same time period.
Ethics
This study did not involve human or animal subject and
thus does not require any approval from an ethics
committee.
Results
Normalization of free-text eligibility criteria
Out of a total of 67 eligibility criteria from the three
studies, 50/67 (74.6%) were considered to be complex
based on the Ross classification. The normalized criteria
are presented in Additional file 2. After normalization:
the DERENEDIAB study was represented by 20 criteria
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(10 for inclusion and 10 for exclusion), aXa study cases
were represented by 20 criteria (10 for inclusion and 10
for exclusion), aXa controls by 11 criteria (6 for inclu-
sion and 5 for exclusion), and EWING by 15 (10 for in-
clusion and 5 for exclusion). Thirty-two (47.8%) criteria
were modified during the normalization process.
Recognition of individual medical concepts: We identi-
fied 114 distinct medical concepts from 67 criteria.
Expressing and querying eligibility criteria with the
EHR4CR platform
a/.Mapping to the terminologies used by the EHR4CR
platform:
Of the 114 identified medical concepts, 92 (81%)
concepts were mapped to EHR4CR terminologies at
the time of this report.
Twenty-three (20.2%) of these medical concepts
corresponded to information present only in non-
structured data in HEGP-CDW or UKM-EHR, and
were not mapped to any EHR4CR terminologies
(e.g. “pulmonary artery”, “dyspnea”, “acute pulmonary
heart disease”). Two concepts could not be mapped
to any of the EHR4CR terminologies at the time of
this report: “active cancer” and “ewing sarcoma”.
At the end of the process, 51 criteria were
computable. All of the computable criteria could be
expressed using the ECLECTIC syntax. Of the 67
original criteria, 43 (64,2%) had at least a satisfactory
agreement to the original criteria, and the
concordance for 23 (34,3%) was considered to be
perfect. The agreement was considered to be
undecided or not satisfactory for 11 (16,4%) and the
translation to computable criteria could not been
performed for 13 (19,4%) (Table 4).
b/.Mapping medical concepts expressed using EHR4CR
terminologies to i2b2 CDW local terminologies. We
mapped 86/92 (93,5%) expressed medical concepts
using EHR4CR terminologies to one or more
concepts of the local terminologies.
c/.Coverage of the CDW (Table 5)
Twenty-three (20,2%) of the 114 distinct medical
concepts corresponded to information present in a
non-structured format in the CDW (e.g. “pulmonary
artery”, “dyspnea”, “pulmonary heart disease”), and 89
(78,1%) to structured data. Two concepts were con-
sidered to be “missing”: “Protein/Creatinine Ratio
Urine” and “Lansky score”.
d/.Completeness
Data completeness was assessed in the HEGP-CDW
and report for each medical concept that was indi-
vidualized during the normalization process. The re-
sults are reported in Additional file 3.
Discussion
The re-use of medical data contained in EHRs is a crit-
ical issue for clinical research as it could have a major
impact on the overall cost of future clinical studies.
CTRSSs have been developed to support clinical re-
search at each step of the process of clinical research.
The objective of this work is to describe all the necessary
tasks for the purpose of re-using the EHR4CR platform
at a local level to support existent academic studies. We
identified specific issues that could have an impact on
the future results of the platform. We also provided
metrics to report these critical aspects that could also be
used for future reports of CTRSS assessment studies.
The normalization process, i.e. transforming a raw
eligibility criterion into a computable criterion, was one
of these critical aspects. Most of our final computable
criteria (64,2% 43/67) were considered to be at least sat-
isfactory by our expert in clinical research. The choice of
working with internationally recognized medical termin-
ologies had an impact on this result. We were able to
map 75% of the medical concepts identified in the ori-
ginal criteria to the locally used terminologies from our
EHR. These important results highlight the fact that
technical specifications of both EHRs and CTRSSs are a
major concern for re-using routine care data for clinical
research purposes.
Translating free-text eligibility criteria into computable
criteria
Terminologies
One of the major limiting aspects of the translation of
free-text eligibility criteria into computable criteria is the
Table 4 Agreement between Original Criteria and Computed Criteria using a Likert Scale










5: Perfect without information loss 8 4 6 5 23
4: Satisfactory 4 4 6 6 20
3: Undecided 1 0 0 2 3
2: Not satisfactory 2 1 5 0 8
1: Not done 5 3 3 2 13
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choice of the terminologies. Most eligibility criteria are
expressed in natural language and not as medical con-
cepts. Several options are available. The Unified Medical
Language System (UMLS®) is the most complete choice
and offers the benefit of its interoperability with many
medical terminologies but may be too broad in scope for
clinical research. Members of the EHR4CR project de-
cided to work with various international standardized
terminologies covering various medical domains. The se-
lected terminologies allowed us to express 81% (92/114)
of the medical concepts contained in the original
criteria.
There are several benefits for using standards, includ-
ing, but not limited to, (a) more synonyms available for
semi-automated matching, or concept identification, (b)
reduced risk of misunderstanding, (c) sharing across
recruitment platforms, which would be difficult
otherwise.
The choice of a terminology set is important and has a
major impact on the number of free-text eligibility
criteria that can be transformed into suitable comput-
able criteria.
Syntax complexity
Criteria are organized into concepts such as age, gender,
disease, symptoms, medical history, and are often con-
nected with comparators including Booleans and others
such as “at least”, “more than” or “if then” conditions.
This complexity could result in difficulties to express eli-
gibility criteria as computable criteria. The choice of
syntax is a second key issue because it affects the ability
to translate the eligibility criteria into computable
criteria. Weng et al. [21] identified several solutions in-
cluding (a) re-using the syntax of existing languages
such as the Structured Query Language (SQL), (b) devel-
oping dedicated syntax e.g. the Arden syntax, or GELLO,
(c) logic-based languages, or (d) ad hoc solutions [22–
24]. The EHR4CR group decided to develop its own so-
lution called ECLECTIC [19]. We expressed all the aXa
and DERENEDIAB trial computable criteria using
ECLECTIC. This second issue is also crucial because it
determines the ability of the platform to express “real
world” eligibility criteria and therefore has a direct
impact on the final performance.
Normalization process
One of the key issues of the normalization process is the
criteria complexity. By analyzing 1000 eligibility criteria
randomly selected in ClinicalTrials.gov, Ross J. et al.
found that 85% contained semantic complexity and that
36,8% were not comprehensible or require clinical judg-
ment or additional metadata [20]. The complexity of our
criteria (74.6% (50/67)) comparable to that of other
studies.
The pre-processing of free-text eligibility criteria for
normalization is necessary for obtaining simple and use-
ful computable criteria. Only 53.7% (36/67) of the cri-
teria did not need any modification to be computed
after normalization. This step remains difficult to auto-
mate and often requires expert input to remove seman-
tic ambiguity, to extend free-text medical concepts, and
for concept recognition. For example, the sixth aXa
Table 5 Results of the normalization process for three institutional studies





Criteria before normalization 20 12 20 15 67
Complex criteria 15 (75%) 10 (83%) 15 (75%) 10 (67%) 50 (75%)
Unchanged criteria 9 (45%) 8 (67%) 10 (50%) 9 (60%) 36 (54%)
Criteria after normalization 20 (100%) 11 (92%) 20 (100%) 15 (100%) 66 (99%)
MEDICAL CONCEPTS
Individual medical concepts identified in free-text eligibility criteria 45 16 39 14 114
Medical concepts mapped to EHR4CR terminologiesa 30 (67%) 15 (94%) 38 (97%) 9 (64%) 92 (81%)
Medical concepts mapped from EHR4CR terminologies to local
terminologies
30 (67%) 15 (94%) 34 (87%) 7 (50%) 86 (75%)
Free-text medical concepts present and structured in the local
CDW/EHR
30 (67%) 16 (100%) 34 (87%) 9 (64%) 89 (78%)
Free-text medical concepts present and unstructured in the local
CDW/EHR
15 (33%) 0 (0%) 4 (10%) 4 (29%) 23 (20%)
Free-text medical concepts missing in the local CDW/EHR 0 (0%) 0 (0%) 1 (3%) 1 (7%) 2 (2%)
FINAL COMPUTABLE CRITERIA 14 8 17 12 51
a medical concepts that correspond to unstructured data in local CDW/EHR were not mapped to EHR4CR terminologies
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criterion, containing 14 medical concepts consisting of
unstructured data, received a note of 5 “translated with-
out any loss of information” by our clinical research ex-
pert. This apparently astonishingly good result was
explained by the association of very specific diagnostic
conditions (e.g. “pulmonary embolism confirmed by a
gap in a pulmonary artery” or “Lower extremity Deep
vein thrombosis confirmed by the lack of compressibil-
ity of a vein segment under the ultrasound probe”) com-
bined to non-useful information (in this context)
immediately identifiable by an expert. The EHR4CR plat-
form queries EHR billing codes and therefore already
works with confirmed diagnoses.
The translation of free-text criteria into medical con-
cepts is a difficult and crucial task. To limit the risk of
introducing bias and to better manage subjective topics,
complex criteria should be reviewed - or better inde-
pendently translated - by two or more experts. More-
over, a good comprehension of the content of data
warehouse is needed to ensure quality mappings (espe-
cially to manage negation in an open world assumption
in which the absence of information is not equivalent to
the negation)
Identifying medical concepts using the platform
terminologies
The second part of the mapping process consists of con-
necting the translated computable criteria now trans-
lated into biomedical concept from standard
terminologies to local EHRs terminologies. Many auto-
mated solutions have been proposed but human expert-
ise is still needed to insure high quality mapping. We
were able to map 93,5% (86/92) of the medical concepts
represented by EHR4CR terminologies to the locally
used terminologies. This success is because many of the
EHR4CR terminologies were also used in the local
CDWs.
While information in EHRs is often structured,
mapping concepts of structured eligibility criteria to
medical concepts collected in a care context is chal-
lenging: (a) terminologies used to translate eligibility
criteria are not necessarily the same as those used for
storing routine care data in EHRs and (b) there is
not always a direct relationship between these differ-
ent terminologies. For example, “Protein/Creatinine
Ratio in urine” would have required a concomitant
determination of protein and creatinine in urine and
a calculation to be mapped. Similarly, one simple
concept could be potentially represented in EHRs in
various forms. For example, patients with “Acute Kid-
ney Disease” could be identified in EHRs using diag-
nosis codes, laboratory results, or free-text. Some
studies have developed computer algorithms to iden-
tify specific patients with EHR data [25, 26]. Natural
language processing tool functionalities of the
EHR4CR platform were not available during this
work. Therefore, we did not map the medical con-
cepts that corresponded to unstructured data to
EHR4CR terminologies. This was possible because the
medical informatics experts responsible for the
normalization process had a perfect knowledge of the
CDW contents.
Structured data completeness and missing data of EHRs
to support clinical research
Structured data are the easiest to use in the implementa-
tion of a CTRSS but these data are collected for pur-
poses other than patient recruitment into clinical trials.
Nevertheless, we found that 78% (89/114) of the medical
concepts present in the aXa, DERENEDIAB and EWING
2008 criteria corresponded to structured data. This is
more than the 55% identified by Köpcke et al. who
worked on the EHRs from five German University Hos-
pitals [27]. This may be because the definition of med-
ical concepts in our study was not exactly the same as in
theirs resulting in differences between the results of the
two studies. Future studies aiming to assess CTRSS per-
formance need to specify the data completeness for each
medical concept to provide comparable outcomes.
Missing data is another crucial point that must be
carefully addressed during the normalization process.
Missing data will influence the results of the platform
and this influence will be highly variable depending on if
these missing values concern the inclusion or the exclu-
sion criteria. Indeed, eligibility criteria with a high preva-
lence of missing data decrease the sensitivity of the
platform because all eligibility criteria are associated
with “AND” operators in the platform. For example, the
use of contraception or not is is far from being reported
for all women in the HEGP-CDW. Eligibility criteria
containing this concept decrease the number of identi-
fied patients. Missing data also increase the number of
patients falsely identified and therefore the specificity of
the platform because all exclusion criteria are associated
with “AND NOT” operators. Another important issue is
that missing data are not objectively quantifiable in a
CDW. Thus, local expertise from people with a complete
knowledge of the queried CDW and a perfect under-
standing of the objectives of the future supported trials
are absolutely necessary before using the platform.
Completeness was evaluated for the entire data ware-
house. Such an evaluation is relevant for items such as
gender. Low completeness for a given criterion may ex-
clude participation of a medical center. However, for
specific results, completeness is only relevant for a sub-
set of patients for whom the information is needed (e.g.
HbA1c for diabetic patients).
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Time issues
Another critical issue from the point of view of the
CTRSS user is the question of time. Each eligibility cri-
terion may vary over time: new biological measurements,
drug therapies, diagnoses, etc. The frequency with which
the database is queried will have an influence on the re-
sults and especially on the sensitivity of the CTRSS. In
most cases, data contained in CDWs are not real-time
data. For example, to be collected in our CDW, diagno-
ses must be 1/ coded by the physician and 2/ imported.
Any real-time inclusion study (e.g. inclusion at diagnosis
or immediately after) is problematic, especially for acute
diseases.
Feasibility of the approach
The process described in this study is time consuming.
In our case, the mapping and translation of the criteria
was performed successfully by an expert physician expe-
rienced in medical informatics and with a strong know-
ledge of the content and structure of the local clinical
data warehouse. If the platform such as EHR4CR were
to be developed, specialized support team composed of
medical informatics specialists and data-manager would
probably be needed to enable scalability.
General statements about the EHR4CR normalization (or
standardization) pipeline
 Semantic interoperability is one of the main
challenges to address to enable the reuse of hospital
EHR data to support research. Semantic
interoperability within a broad international research
network reusing clinical data from EHRs requires a
rigorous governance process to ensure the quality of
the data standardization process.
 This study demonstrates good coverage of the
EHR4CR central terminology used during the
normalization process of the eligibility criteria of
three studies. However, its scope needs to be
continuously extended to address the representation
of a much broader set of eligibility criteria. Updating
of the EHR4CR central terminology cannot be fully
automated (e.g. through automatic coding of free
text clinical trial protocols). A collaborative editor is
required to efficiently support the creation of new
semantic resources to expand the scope to
additional studies and associated eligibility criteria.
 Despite recent efforts, formal representation of
multimodal and multi-level data that supports data
interoperability across clinical research and care do-
mains is still challenging.
 Terminology mapping at hospital sites is the major
bottleneck of the data standardization pipeline.
Supportive tools are still in their infancy.
Conclusion
Only a limited number of studies have assessed the ef-
fectiveness of CTRSSs with respect to their sensitivity,
specificity and impact on recruitment rate [7]. By trying
to re-use the EHR4CR platform for three local institu-
tional studies, we identified a set of issues that may
affect the future performance of the platform. These
must be specified in future reporting of the assessment
of CTRSS accuracy. The recommendations of Köpcke et
al. for future reporting of CTRSS performance is based
on the literature. In contrast, our recommendations are
based on our practical experience in deploying institu-
tional studies (Table 6). We aim to provide strengthened
recommendations for future CTRSS reporting that will
insure (i) the exact reproducibility of the inclusion/ex-
clusion criteria execution, (ii) a fair comparison of the
query execution results, and hence of the platforms
themselves. Additional work by domain experts is still
needed to harmonize these efforts.
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Table 6 Recommendations: Informations that Should be Specified
in Future CTRSS Assessment Reporting from the CTRSS User Point
of View
Normalizing Eligibility Criteria
1- The number of free-text eligibility criteria, and their complexity;
2- The terminologies and syntax that have been used to represent
eligibility criteria;
3- The concordance between the original free-text eligibility criteria and
the final computable criteria;
4- The quality of the mapping, i.e., the proportion of concepts that have
been successfully mapped;
5- If human expertise is necessary at each step of the process and how
it could affect the results;
Time Issue
6- How often the EHR has been queried and for what period of time;
Structured Data Completeness of EHR
7- The completeness of the database(s) for each eligibility criterion, i.e. is
the data available and for what proportion of patients?
8- If the platform was used to query structured data, unstructured data
or both;
9- How the issue of data completeness has been managed: not
managed, with scoring, Bayesian network, free text mining using
natural
language processing tools…
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